Form 4: Recursion Pharmaceuticals CEO Exercises Stock Options
SEC Form 4 Filing
Christopher Gibson, CEO of Recursion Pharmaceuticals, executed stock options to acquire 5,000 shares of Class A Common Stock at $2.48 per share on August 27, 2024.
Summary
- On August 27, 2024, Christopher Gibson, the CEO of Recursion Pharmaceuticals, exercised stock options to acquire 5,000 shares of Class A Common Stock at a price of $2.48 per share.
- Following this transaction, Gibson directly owns 747,656 shares of Class A Common Stock.
- Gibson also indirectly owns shares through LAHWRAN-3 LLC (486,000 shares), LAHWRAN-4 LLC (388,000 shares), and the Gibson Family Trust (67,875 shares).
- He holds options to purchase additional shares at prices ranging from $8.55 to $11.40, with various vesting schedules and expiration dates.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine transaction. The CEO exercising options is generally a positive sign, but it's not a major event.
Positives
- The CEO's exercise of stock options could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the CEO's stake in the company.
- The exercise of options could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of transaction: CEO exercised stock options to acquire shares. |
| 12/30/2030 | Expiration date of one of the stock option grants. |
| 02/01/2033 | Vesting start date of one of the stock option grants. |
| 02/04/2032 | Expiration date of one of the stock option grants. |
| 02/09/2034 | Vesting start date of one of the stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.